About Worldwide  |     FAQs    |    Careers    |        Media Center  |    Taj Pharmaceuticals |  World   |    TAJ Group

    © 2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved

fast-growing Midlands company

      India              Latin America/ Caribbean            Africa & Middle East              Asia              Russia              Europe

Active Pharmaceutical Ingredients
   Pharmaceuticals API List
   Product Development
   Product Search
   Agro Chemicals
   Custom Pharma Services
   Contact Us
production process MEDIA CENTERS / UPDATED NEWS






HOME >> Media Center


Taj Pharmaceuticals Limited, a fast-growing Midlands company which produces specialist prescription generic & Raw materials pharmaceuticals, Focus, based in develops non-standard generic drugs which are outside the expertise of the major pharmaceutical companies operating in the generic export In particular, its portfolio comprises World specific products,generally oral liquids, injectables, lotions and ointments that are difficult to source, develop and licence. The company was formed
through a management buy-out from india.

Today the division boasts of a field force of more than 700 field personnel and a turnover of almost 20 crore per annum. Encouraged by its success in May 2000, the company launched their new concern, tajlifesciences Pharma. According to the information posted on the website of the company, today the division boasts of a field force of more than 700 field personnel and turnover of almost 20 crore (2000-2007). On the number front, Crore in 2006-07. This is a 43.17 percent rise Cover Rs 20 crore-the total export for earlier year.

     Pharma update News

 >>  Hirandani Hospital gets govt clearance for services in western India
 >>  Springer India launches Dentistry in India
>>  Taj Pharma expands generic portfolio through licensing with Tajlifesciences Pharma.        
>>   Workshop on 'Methods in Epidemiological Research' in Chennai from May 31

>>   Pharma MNCs record just 2% growth in net profit, sales up by 9.4% during 2008

>>   Taj  Pharma completes phase 2a trial for urology drug.

   >>   Genetic tests before prescription of drugs necessary: Medco expert.

>>   Cancer, heart diseases have connection with diabetes Expert.

AP Drug Dept directs Piramal Healthcare to recall batch of anti-diabetes drug from market.

    >>   New Product Introduced : Oseltamivir Phosphate, Phenyl Propanolamine, Phenylephrine, Etafedrine

   Midlands company   operatingTaj Pharma company
Taj Pharmaceuticals API Logo


Media Center

Copyright © Taj Pharmaceuticals Ltd. | Privacy Policy | Terms & Conditions | Sitemap

Investor Relations    Feedback     Contact Worldwide    Sitemap


taj group logo
Active Pharmaceutical Ingredients manufacturer, exporter, drug ingredients, pharmaceuticals, India
© 2004 - 2009
Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals  Ltd products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals  Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.